Nutrien (NTR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Apr, 2026Executive summary
Achieved adjusted EBITDA of $6.05 billion in 2025, up 13% year-over-year, with net earnings of $2.30 billion, record fertilizer sales volumes, and strong execution of strategic and cost reduction plans, boosting Retail adjusted EBITDA and shareholder returns.
Raised potash sales guidance twice, achieved 49% mine automation, and maintained potash controllable cash cost at $58/ton, below the $60/ton goal.
Generated $900 million from non-core asset divestitures, including Profertil and Sinofert, and reduced short-term debt by over $600 million.
Increased cash return to shareholders by 30% through share repurchases and stable dividends, with shares outstanding down 4.9% from 2023 to 2025.
Executed portfolio simplification and closed over 50 underperforming retail locations, reducing headcount by 400+ positions.
Financial highlights
Adjusted EBITDA reached $6.05 billion in 2025, a 13% increase from the prior year, with net earnings of $2.30 billion and sales of $26.89 billion.
Retail adjusted EBITDA rose to $1.74 billion, surpassing cost savings targets, with Potash at $2.25 billion, Nitrogen at $2.15 billion, and Phosphate at $382 million.
Capital expenditures reduced to $2 billion, below the $2.2-$2.3 billion target.
Free cash flow structurally increased, supporting debt reduction and higher shareholder returns.
Diluted net earnings per share for 2025 were $4.66, up 243% from 2024; adjusted net EPS was $4.56, up 31%.
Outlook and guidance
2026 guidance projects Retail adjusted EBITDA of $1.75–$1.95 billion, Potash sales volumes of 14.1–14.8 million tonnes, Nitrogen sales volumes of 9.2–9.7 million tonnes, and Phosphate 2.4–2.6 million tonnes.
Capital expenditures for 2026 guided at $2–$2.1 billion, with $400 million for growth investments.
Effective tax rate on adjusted net earnings expected at 24.0–26.0%.
Nitrogen margin profile expected to improve due to operational enhancements and facility shutdowns.
Continued review of strategic alternatives for phosphate, Trinidad, and Brazilian retail businesses.
Latest events from Nutrien
- Global agricultural input leader files to offer multiple securities for flexible capital needs.NTR
Registration filing31 Mar 2026 - Disciplined capital strategy and strong market demand drive growth, with portfolio shifts underway.NTR
Bank of America 2026 Global Agriculture and Materials Conference25 Feb 2026 - Structural growth, portfolio optimization, and strong market positioning drive future outlook.NTR
35th BMO Global Metals, Mining & Critical Minerals Conference24 Feb 2026 - Record EBITDA growth and rising shareholder returns driven by strong fertilizer sales and cost discipline.NTR
Investor presentation23 Feb 2026 - Record potash sales and Retail margins offset lower prices and Brazil impairment.NTR
Q2 20242 Feb 2026 - Targets $1.9–$2.1B Retail EBITDA, $200M cost savings, and core asset growth by 2026.NTR
Investor Day 20241 Feb 2026 - Record Potash volumes and cost savings offset lower prices, supporting improved 2024 outlook.NTR
Q3 202415 Jan 2026 - Q1 2025 earnings fell, but guidance and capital priorities remain strong amid tight fertilizer markets.NTR
Q1 20258 Jan 2026 - Record potash volumes and strong Retail margins drive robust 2024 results and positive 2025 outlook.NTR
Q4 20248 Jan 2026